UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Growth inhibition of human ovarian cancers by cytotoxic analogues of luteinizing hormone-releasing hormone

JNCI : Journal of the National Cancer Institute, 1997-12, Vol.89 (23), p.1803-1809

1997

Volltextzugriff (PDF)

Diabetes and diabetes-associated lipid abnormalities have distinct effects on initiation and progression of atherosclerotic lesions

The Journal of clinical investigation, 2004-09, Vol.114 (5), p.659-668

2004

Volltextzugriff (PDF)

Chronic administration of the luteinizing hormone-releasing hormone (LHRH) antagonist cetrorelix decreases gonadotrope responsiveness and pituitary LHRH receptor messenger ribonucleic acid levels in rats

Endocrinology (Philadelphia), 1996-08, Vol.137 (8), p.3430-3436

1996

Volltextzugriff (PDF)

Inhibition of growth of MDA-MB-231 human breast cancer xenografts in nude mice by bombesin/gastrin-releasing peptide (GRP) antagonists RC-3940-II and RC-3095

European journal of cancer (1990), 1998-04, Vol.34 (5), p.710-717

1998

Volltextzugriff (PDF)

Hyperlipidemia in concert with hyperglycemia stimulates the proliferation of macrophages in atherosclerotic lesions: Potential role of glucose-oxidized LDL

Diabetes (New York, N.Y.), 2004-12, Vol.53 (12), p.3217-3225

2004

Volltextzugriff (PDF)

Expression of mRNA for luteinizing hormone-releasing hormone receptors and epidermal growth factor receptors in human cancer cell lines

International journal of oncology, 1998-03, Vol.12 (3), p.671

1998

Volltextzugriff (PDF)

Androgen Receptor Polymorphisms and the Incidence of Prostate Cancer

Cancer epidemiology, biomarkers & prevention, 2002-10, Vol.11 (10), p.1033-1040

2002

Volltextzugriff (PDF)

Growth Hormone-Releasing Hormone Antagonist MZ-5-156 Inhibits Growth of DU-145 Human Androgen-Independent Prostate Carcinoma in Nude Mice and Suppresses the Levels and mRNA Expression of Insulin-Like Growth Factor II in tumors

Proceedings of the National Academy of Sciences - PNAS, 1998-07, Vol.95 (15), p.8864-8868

1998

Volltextzugriff (PDF)

Polymorphic markers in the 5α‐reductase type II gene and the incidence of prostate cancer

International journal of cancer, 2003-07, Vol.105 (4), p.480-483

2003

Volltextzugriff (PDF)

Cytotoxic analogs of luteinizing hormone-releasing hormone bind with high affinity to human breast cancers

Cancer letters, 1999-03, Vol.136 (2), p.129-136

1999

Volltextzugriff (PDF)

Targeted cytotoxic analog of luteinizing hormone–releasing hormone AN-207 inhibits growth of OV-1063 human epithelial ovarian cancers in nude mice

American journal of obstetrics and gynecology, 1999-05, Vol.180 (5), p.1095-1103

1999

Volltextzugriff (PDF)

Bombesin/gastrin‐releasing peptide antagonists RC‐3095 and RC‐3940‐II inhibit tumor growth and decrease the levels and mRNA expression of epidermal growth factor receptors in H‐69 small cell lung carcinoma

Cancer, 1998-10, Vol.83 (7), p.1335-1343

1998

Volltextzugriff (PDF)

Decrease in the level and mRNA expression of LH-RH and EGF receptors after treatment with LH-RH antagonist cetrorelix in DU-145 prostate tumor xenografts in nude mice

International journal of oncology, 1998-09, Vol.13 (3), p.429

1998

Volltextzugriff (PDF)

A Single in vivo Administration of Bombesin Antagonist RC-3095 Reduces the Levels and mRNA Expression of Epidermal Growth Factor Receptors in MXT Mouse Mammary Cancers

Proceedings of the National Academy of Sciences - PNAS, 1997-09, Vol.94 (20), p.10913-10918

1997

Volltextzugriff (PDF)

Luteinizing hormone–releasing hormone (LH–RH) antagonist Cetrorelix inhibits growth of DU-145 human androgen-independent prostate carcinoma in nude mice and suppresses the levels and mRNA expression of IGF-II in tumors

Regulatory peptides, 1998-10, Vol.77 (1), p.185-192

1998

Volltextzugriff (PDF)

Calcitonin and calcitonin gene-related peptide in the shrimp, Palaemon serratus: Variations during the molt cycle

Comparative biochemistry and physiology. A, Comparative physiology, 1992-08, Vol.102 (4), p.679-682

1992

Volltextzugriff (PDF)

1 – 16 von 16

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(13)
Mit Volltextzugriff
(14)

Publikationsform

Artikel
(16)

Sprache

Englisch
(16)

Erscheinungsjahr

n.n

Thema

Science & Technology
(14)
Life Sciences & Biomedicine
(13)
Biological And Medical Sciences
(12)
Animals
(11)
Medical Sciences
(11)
Mice
(10)
Humans
(9)
Male
(8)
Mice, Nude
(8)
Oncology
(8)
Tumor Cells, Cultured
(7)
Antineoplastic Agents
(6)
Female
(6)
Gonadotropin-Releasing Hormone - Analogs & Derivatives
(6)
Pharmacology. Drug Treatments
(6)
Blotting, Southern
(5)
Chemotherapy
(5)
Neoplasm Transplantation
(5)
Rna, Messenger - Metabolism
(5)
Cell Division - Drug Effects
(4)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Growth inhibition of human ovarian cancers by cytotoxic analogues of luteinizing hormone-releasing hormone

Diabetes and diabetes-associated lipid abnormalities have distinct effects on initiation and progression of atherosclerotic lesions

Chronic administration of the luteinizing hormone-releasing hormone (LHRH) antagonist cetrorelix decreases gonadotrope responsiveness and pituitary LHRH receptor messenger ribonucleic acid levels in rats

Inhibition of growth of MDA-MB-231 human breast cancer xenografts in nude mice by bombesin/gastrin-releasing peptide (GRP) antagonists RC-3940-II and RC-3095

Hyperlipidemia in concert with hyperglycemia stimulates the proliferation of macrophages in atherosclerotic lesions: Potential role of glucose-oxidized LDL

Expression of mRNA for luteinizing hormone-releasing hormone receptors and epidermal growth factor receptors in human cancer cell lines

Androgen Receptor Polymorphisms and the Incidence of Prostate Cancer

Growth Hormone-Releasing Hormone Antagonist MZ-5-156 Inhibits Growth of DU-145 Human Androgen-Independent Prostate Carcinoma in Nude Mice and Suppresses the Levels and mRNA Expression of Insulin-Like Growth Factor II in tumors

Polymorphic markers in the 5α‐reductase type II gene and the incidence of prostate cancer

Cytotoxic analogs of luteinizing hormone-releasing hormone bind with high affinity to human breast cancers

Targeted cytotoxic analog of luteinizing hormone–releasing hormone AN-207 inhibits growth of OV-1063 human epithelial ovarian cancers in nude mice

Bombesin/gastrin‐releasing peptide antagonists RC‐3095 and RC‐3940‐II inhibit tumor growth and decrease the levels and mRNA expression of epidermal growth factor receptors in H‐69 small cell lung carcinoma

Decrease in the level and mRNA expression of LH-RH and EGF receptors after treatment with LH-RH antagonist cetrorelix in DU-145 prostate tumor xenografts in nude mice

A Single in vivo Administration of Bombesin Antagonist RC-3095 Reduces the Levels and mRNA Expression of Epidermal Growth Factor Receptors in MXT Mouse Mammary Cancers

Luteinizing hormone–releasing hormone (LH–RH) antagonist Cetrorelix inhibits growth of DU-145 human androgen-independent prostate carcinoma in nude mice and suppresses the levels and mRNA expression of IGF-II in tumors

Calcitonin and calcitonin gene-related peptide in the shrimp, Palaemon serratus: Variations during the molt cycle

Suchergebnisse filtern